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Jensen et al. report the crystal structure of a human fibrillin-1 hybrid domain in this issue of Structure. This
domain is found exclusively in the fibrillin/latent transforming growth factor-b binding protein superfamily
and shares structural features with two other domains in these proteins, the TB/8-Cys and the cbEGF
domains.Fibrillins are extended 350-kDa extracel-
lular matrix proteins that constitute the
backbone of microfibrils, large molecular
machines found in elastic and nonelastic
tissues. Microfibrils play important roles
in thebiogenesisof elastic fibers, inconfer-
ring limited elasticity to tissues, and in the
regulation of bioavailability of transforming
growth factor-b superfamily members.
Similar to othermatrix glycoproteins, fibril-
lins display a tandemly arrayed domain
organization, with each domain represent-
ing an individual folding unit. Fibrillins,
together with the latent transforming
growth factor-b binding proteins (LTBPs),
form a superfamily of proteins character-
ized by the presence of two unique do-
mains: the transforming growth factor-b
binding protein-like (TB or 8-Cys) do-
mains, and the hybrid (hyb) domains
(Figure 1).
The limitations for high resolution struc-
tural studies of the full-length fibrillins are
their large molecular mass combined with
a relatively low solubility, the extremely
high number of cysteine residues (361 in
fibrillin-1, equivalent to 12.6%), almost all
engaged in disulfide-bridges, and the
extensive post-translational modifications,
including N-glycosylation (Figure 1).
However, it has been demonstrated that
individual domains of fibrillin-1 or arrays of
a few adjacent domains can be efficiently
expressed in bacterial systems and re-
folded in vitro into correctly folded proteins
(Knott et al., 1996). Using this experimental
approach, high resolution structures of fi-
brillin-1 calcium-binding epidermal growth
factor-like (cbEGF) domains and TB/8-Cys
domains have been solved successfully
(Downing et al., 1996; Lee et al., 2004).
The hyb1 domain in fibrillins mediates
interactions with fibulin-2, 4, and 5,as well as with LTBP-1 and4 (El-Hallous
et al., 2007; Ono et al., 2009). In addition, it
was shown that this domain participates in
intermolecular disulfide-bond formation
during microfibril assembly (Reinhardt
et al., 2000). No functional assignments
have been delineated for the hyb2 domain
in fibrillins. The initial primary sequence
analysis of the TB/8-Cys, hyb, and cbEGF
domains revealed similarities of the hyb
domains’ N termini with the N terminus of
TB/8-Cys domains, and of the hyb
domains’ C termini with the C terminus of
cbEGF domains (Corson et al., 1993).
With the new high resolution (1.8 A˚) crystal
structure of a hyb domain from human
fibrillin-1 (hyb2) reported by Jensen et al.
(2009), it is nowclear that these similarities
in the primary sequence are fully reflected
in the structure, proving that the hyb
domain is indeed an evolutionary ‘‘hybrid’’
between TB/8-Cys and cbEGF domains.
The overall structure of hyb2 flanked by
cbEGF9 and cbEGF10 is similar to the
structure of the TB/8-Cys domains in
regard to the positions of characteristic
side chains. In the central a-helical region
of bothdomains, the ‘‘Cys-Cys-Cys’’motif
of the TB/8-Cys domain and the corre-
sponding ‘‘Cys-Cys’’ motif in hyb2 are
found in similar locations. In addition,
a conserved cis-proline is placed in a cor-
responding structural region in both
domains. In contrast to the TB/8-Cys
structure, the hyb2 domain is missing
a second a-helical stretch toward its
C-terminal end.Another elementary differ-
ence between the two domainswas found
in the disulfide-bond patterns. Both do-
mains contain eight cysteine residues;
however, the hyb2 domain lacks one of
the three cysteines in the ‘‘Cys-Cys-Cys’’
motif of the TB/8-Cys domain, but hasStructure 17, May 13, 2009two cysteine residues in its C terminus as
opposed to one. These differently posi-
tioned cysteine residues result in a 1-3,
2-5, 4-6, 7-8 disulfide-bond pattern in the
hyb domain, versus a 1-3, 2-6, 4-7, 5-8
pattern characteristic for the TB/8-Cys
domain. In this context it will be interesting
to determine the structure of the hyb1
domain of fibrillin-1, which contains an
additional cysteine residue at position
204 and consequently has one unpaired
cysteine. This extra cysteine residue in the
hyb1 domain is conserved between all
fibrillins and between all species. Hyb
domains in LTBPs, on the other hand, do
not have such an extra cysteine residue.
Biochemical data previously suggested
that cysteine 204 of fibrillin-1 occurs as a
free thiol on the surface of the molecule,
making it an ideal candidate for inter-
molecular crosslink formation (Reinhardt
et al., 2000). Molecular modeling of the
hyb1 domain of fibrillin-1, based on the
experimentally determined hyb2 coordi-
nates presented in Jensen et al. (2009),
supports this proposed role for the un-
paired cysteine.
The affinity for calcium binding to
cbEGF domains in fibrillin-1 depends
strongly on the nature of the inter-domain
interfaces between adjacent domains.
These contacts can modulate the affinity
for calciumover awide range (dissociation
constants from nanomolar to millimolar).
The cbEGF domains directly downstream
of the TB/8-Cys domains frequently bind
calcium with very high affinity attributed
to hydrophobic domain interactions
between the TB/8-Cys and the cbEGF
domains (Jensen et al., 2005). In Jensen
et al. (2009), the authors demonstrate
that the cbEGF domains succeeding the
hyb1 and hyb2 domains of fibrillin-1 alsoª2009 Elsevier Ltd All rights reserved 635
Figure 1. Domain Organization of the Human Fibrillin/LTBP Superfamily Members
The domains discussed in this preview are indicated in color. Jensen et al. (2009) solved the structure of
the hyb2 domain (H2, blue) in the context of its flanking cbEGF9 and cbEGF10 domains as indicated. The
hyb1 domain (H1, blue) of all fibrillins contain an additional unpaired ninth cysteine residue, while the hyb
domains in LTBPs do not contain such an extra cysteine. For simplicity, only the longest splice variant of
each LTBP is displayed.
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dissociation constants in the low nanomo-
lar range, which is again explained by the
extensive domain interactions at least
observed between hyb2 and cbEGF10.
Under physiological calcium concentra-
tions (1.5 mM), the region around hyb2
adopts a near linear shape. Together
with previously published structural data
available for the TB/8-Cys domains and636 Structure 17, May 13, 2009 ª2009 Elseviseveral cbEGF domains in their natural
domain context, the authors predict the
region between cbEGF3 and cbEGF43
(i.e., themajority of the fibrillin-1molecule)
to form an extended structure, as sug-
gested by low resolution methods that
include electron microscopy after rotary
shadowing (Sakai et al., 1991). This infor-
mation will be very useful to validate exist-
ing models for fibrillin organization iner Ltd All rights reservedmicrofibrils and to correlate the structure
with specific functions.
To fully understand the structure,
macromolecular organization, and, ulti-
mately, the functions of fibrillins, it will be
necessary to solve the structure of (1) the
proline/glycine-rich domains in fibrillins,
(2) the N- and C-terminal unique domains,
(3) larger contiguous portions of the
proteins, (4) functional protein and self-
interaction sites, and (5) fully assembled
fibrillin-1 aggregates giving rise tomicrofi-
brils. These are challenges for the future.
Fornow, thefibrillin-1hyb2structure isone
more piece added to the fibrillin puzzle.ACKNOWLEDGMENTS
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